(1.26%) 5 127.79 points
(1.18%) 38 676 points
(1.99%) 16 156 points
(0.40%) $78.42
(1.73%) $2.18
(0.13%) $2 311.50
(0.62%) $26.86
(0.29%) $968.10
(-0.35%) $0.929
(-1.19%) $10.86
(-0.12%) $0.797
(0.52%) $91.61
5 days till quarter result
(bmo 2024-05-10)
Expected move: +/- 0.00%
Live Chart Being Loaded With Signals
Xvivo Perfusion AB (publ), a medical technology company, develops solutions for organ, tissue, and cell preservation and perfusion in connection with transplantation in Sweden, the United States, North America and South America, Europe, the Middle East, Africa, and the Asia Pacific...
Stats | |
---|---|
本日の出来高 | 83 930.00 |
平均出来高 | 64 975.00 |
時価総額 | 11.91B |
EPS | SEK0 ( 2024-04-23 ) |
次の収益日 | ( SEK0.310 ) 2024-05-10 |
Last Dividend | SEK0 ( N/A ) |
Next Dividend | SEK0 ( N/A ) |
P/E | 113.51 |
ATR14 | SEK0.620 (0.16%) |
ボリューム 相関
Xvivo Perfusion AB (publ) 相関
10 最も正の相関 |
---|
10 最も負の相関 |
---|
知っていましたか?
相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。
相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。
Xvivo Perfusion AB (publ) 相関 - 通貨/商品
Xvivo Perfusion AB (publ) 財務諸表
Annual | 2023 |
収益: | SEK597.54M |
総利益: | SEK416.91M (69.77 %) |
EPS: | SEK3.07 |
FY | 2023 |
収益: | SEK597.54M |
総利益: | SEK416.91M (69.77 %) |
EPS: | SEK3.07 |
FY | 2022 |
収益: | SEK415.29M |
総利益: | SEK296.96M (71.51 %) |
EPS: | SEK0.620 |
FY | 2021 |
収益: | SEK258.39M |
総利益: | SEK188.28M (72.87 %) |
EPS: | SEK0.0777 |
Financial Reports:
No articles found.
Xvivo Perfusion AB (publ)
Xvivo Perfusion AB (publ), a medical technology company, develops solutions for organ, tissue, and cell preservation and perfusion in connection with transplantation in Sweden, the United States, North America and South America, Europe, the Middle East, Africa, and the Asia Pacific. The company offers XVIVO System (XPS), an integrated off-the-shelf cardiac bypass system that includes various components needed to safely run normothermic ex vivo lung perfusion (EVLP); XPS Disposable Lung Kit that contains disposables and pre-packed products to suit requirement for sterility; and STEEN Solution, a buffered extracellular solution optimally designed to perfuse the isolated donor lung during EVLP. It also provides Perfadex Plus, an extracellular, low potassium, dextran-based electrolyte preservation solution; XVIVO Silicone Tubing Set for rapid flushing of donor lungs during procurement; and XVIVO LS and XVIVO Disposable Lung Set, a device for EVLP. In addition, the company offers XVIVO Organ Chamber, a single-use sterile disposable container intended to be used as a temporary receptacle for isolated lungs in preparation for eventual transplantation into a recipient; and XVIVO Lung Cannula Set, a single-use, sterile disposable product. The company was incorporated in 1998 and is headquartered in Gothenburg, Sweden.
について ライブシグナル
このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。